Breaking News, Collaborations & Alliances

Shilpa Biologicals, SteinCares to Expand Biosimilar Access in Latin America

A press release did not specify what the biosimilar is.

Author Image

By: Patrick Lavery

Content Marketing Editor

Shilpa Biologicals has signed a licensing agreement with SteinCares to commercialize a biosimilar in the latter’s home region, Latin America. The strategic pact gives SteinCares exclusive rights to register, commercialize, and distribute the biosimilar. Meanwhile, Shilpa Biologicals, a subsidiary of Shilpa Medicare, will handle product development and commercial manufacturing at its Dharwad, India facility. Shilpa and SteinCares Backgrounds SteinCares currently works to expand access to...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters